The importance of endobag use with incision-protective devices in VATS lung resection: a preliminary study.
Carlos Andrés Latorre NogueraAgnaldo Jose LopesIvan Mathias FilhoClaudio HigaRodolfo Acatauassú NunesCarlos Eduardo Teixeira LimaEduardo Haruo SaitoPublished in: BMC research notes (2022)
A total of 47 endobag fluid samples were collected from patients who underwent VATS. The surgical specimen was subjected to histopathological analysis, and all patients underwent pathological TNM staging. In the cytopathological analyses, only 2 (4.3%) specimens of endobag fluid aspirate were positive for neoplastic cells. In these two cases, the tumors were peripheral, both with diagnoses of moderately differentiated adenocarcinoma and with classifications of T1bN0M0 and T3N0M0. These results indicate that although there is a low incidence of tumor cells in endobag fluid, it is always better to perform surgery using all available protective measures to avoid tumor implantation in the thoracic cavity to the greatest extent possible.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- prognostic factors
- minimally invasive
- peritoneal dialysis
- spinal cord
- lymph node
- signaling pathway
- risk factors
- induced apoptosis
- cell death
- spinal cord injury
- coronary artery disease
- pet ct
- atrial fibrillation
- coronary artery bypass
- percutaneous coronary intervention
- oxidative stress
- cell cycle arrest
- rectal cancer